NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
May 19, 2025 $2.01 +14.86% $1.76 V 85.80% 1
May 16, 2025 $1.95 +16.42% $1.75 V 88.57% 1
May 13, 2025 $1.75 +10.06% $2.03 V 86.21% 1
May 12, 2025 $1.65 +7.84% $1.59 V 96.23% 1
May 6, 2025 $1.59 +2.65% $1.43 X 88.73% 0
May 6, 2025 $1.52 -1.66% $1.43 V 93.41% 1
May 6, 2025 $1.65 +6.45% $1.43 X 84.62% 0
Apr 8, 2025 $1.19 +4.22% $1.16 V 97.58% 1
Apr 8, 2025 $1.17 +2.64% $1.16 V 99.13% 3
Apr 8, 2025 Bullish $1.16 X 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE